Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor
Lu, Te-Ling, Chang, Wei-Ting, Chan, Chee-Hong, Wu, Sheng-NanVolume:
10
Language:
english
Journal:
Frontiers in Pharmacology
DOI:
10.3389/fphar.2019.00076
Date:
February, 2019
File:
PDF, 3.09 MB
english, 2019